Lamond David is a director of Quince Therapeutics Inc.
Person profile
Roles
Address
South San Francisco, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Cortexyme, Inc.
9 Jun 22
4
Lucira Health, Inc.
3 Jun 22
4
Applied Molecular Transport Inc.
26 May 22
4
Cortexyme, Inc.
23 May 22
4
Applied Molecular Transport Inc.
23 May 22
4
Cortexyme, Inc.
17 Jun 21
4
Applied Molecular Transport Inc.
20 May 21
SC 13G/A
Cortexyme, Inc.
27 Apr 21
4
Applied Molecular Transport Inc.
7 Apr 21
4
Cortexyme, Inc.
24 Mar 21
Recent insider trades
| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 8 Jun 22 | QNCX Quince Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 3.23 | 27,000 | 87.21 k | 27,000 |
| 1 Jun 22 | LHDX Lucira Health | Stock Option Common Stock | Grant | Acquire A | No | No | 1.85 | 59,459 | 110.00 k | 59,459 |
| 24 May 22 | AMTI Applied Molecular Transport | Stock Option Common Stock | Grant | Acquire A | No | No | 3.13 | 20,000 | 62.60 k | 20,000 |
| 23 May 22 | AMTI Applied Molecular Transport | Common Stock | Buy | Acquire P | Yes | No | 3.26 | 33,500 | 109.21 k | 1,077,519 |
| 20 May 22 | AMTI Applied Molecular Transport | Common Stock | Buy | Acquire P | Yes | No | 3.08 | 33,000 | 101.64 k | 1,044,019 |
| 19 May 22 | QNCX Quince Therapeutics | Common Stock | Grant | Acquire A | Yes | No | 0 | 200,002 | 0.00 | 1,734,722 |